Oncomédica S.A.S (Site 1602)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Colorectal cancer

Closed trials

• Completed

  Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008).

  NCT04895722· Phase 2· Merck Sharp & Dohme LLC· Source